BUZZ - Moderna shares rise after raising its annual revenue growth forecast

November 6 - ** Moderna MRNA.O shares rose 7.27% in premarket trading to $258.07

** The company now expects its total revenue growth rate for 2026 (link) to be between 15% and 25%, exceeding the previous forecast of a maximum 10% growth rate

** According to data compiled by London Stock Exchange Group (LSEG), third-quarter revenue reached $1.3 billion, surpassing analysts' average expectation of $885.1 million

** Net profit for this quarter was $162 million, compared with a net loss of $200 million in the same period last year

** As of the previous trading day's close, the stock had increased more than eightfold for the year

(To assist non-English speakers, Reuters automatically translates its reports into several other languages. As automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for reader convenience. Reuters accepts no responsibility for any damages or losses arising from the use of the automated translation feature.)